bevacizumab,trifluridine tipiracil
taiho pharma,roche,otsuka
[]
 sunlight!!! trifluridine/tipiracil + bev &gt; trifluridine/tipiracil in 3rd line metastatic #colorectalcancer mos benefit of 3.3 months (hr 0.61) is actually huge! bev beyond progression (76% prior anti-vegf) #crcsm #gi23 
GI Medical Oncologist, Associate Professor of Medicine @Georgetown @RueschCenter @LombardiCancer, Ex-@SidwellFriends @Penn @KeckMedUSC keyboardist @BasementRiot